UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Transparency directive : regulatory news

10/07/2020 20:00

https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513= 9PTmAm2ORJ-2Fb7C-2B6ek685axVcn3p-2B-2FENjGJA-2Fz2cPUY6JM6f6b5cbztKuS5B7WZQL= h2OHdh9PFKUBKamm-2BoDSlfmZNPYty5-2FaDKt0s15HxR_xDPID0vOuylFAU8fv4e60wei4Jxq= EGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2= F2X9c9g1wYOft00jWryzO1Yv7N8-2FHtdkmy9lj3HDm0mgwrc7dx-2FAeLCNhnqw-2FZB8PzjCh= c2vwXnzPir7EVkLNkyfI-2F59U9WM0-2Bm0iKjbKos9-2FMnPVn7uNOVPRjraz2Fl-2BCWk0H6s= EWx6Wz-2BDgSGRr8t6qHLnWJ9tjzg5NGB6Na4xJCnv8BtXIGZEVokyuKd2LjwVYaHCppY0r5iSX= XL0LKfWMHRN0wYE4o7o6YE3JOTXTlmGTpNBKauNGRdCm1RgGVHCROOxZU-3D ** Disposals of own shares ------------------------------------------------------------ Brussels (Belgium), 10 July 2020 =E2=80=93 20:00 (CEST) =E2=80=93 regulated= information In accordance with article 8:6 of the Royal Decree executing the Belgian Co= de of Companies and Associations, UCB announces that, following exercises o= f stock options by members of its personnel, it has disposed of UCB shares = OTC in view of deliveries of these shares to the relevant members of the pe= rsonnel, within the framework of the Long Term Incentive Program of the UCB= Group, as follows: https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513= 9PTmAm2ORJ-2Fb7C-2B6ek685axVcn3p-2B-2FENjGJA-2Fz29Pz4-2FWV3rnOZ-2BHzQCdaDba= VlVkXz4AKF1QGVqzcne5XGN7sT6CkEPhExRT8pkVtkM5Gk_xDPID0vOuylFAU8fv4e60wei4Jxq= EGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2= F2X9c9g1wYOft00jWryzO1Yv7N8-2FHtdkmy9lj3HDm0mgwrc7dx-2FAeLCNhnqw-2FZB8PzjCh= c2vwXnzPir7EVkLNkyfI-2F59U9WM0-2Bm0iKjbKos9-2FMnPVn7uN0EcJ40DPANijwbxbnRg3q= lz-2BRD3fzzmrjQGHLIiyh2jIVu05yMfAygwQn3KDsMfErFxUF8CUlxLGcLPmFInhiHvOR3vS3K= It0EBJ3pHkLT0Vwy3sXXwho1gg9hlR1k30udFP0bGAQMnPLgFYUcVkY-3D https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513= 9PTmAm2ORJ-2Fb7C-2B6ek685axVcn3p-2B-2FENjGJA-2Fz218NRD0Rls2dpHe6LmmGzi-2B-2= BBfHJcjQM4zomJjc4Png7fMNfZ7A0GhEmkmpVbnRTKbvv6_xDPID0vOuylFAU8fv4e60wei4Jxq= EGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2= F2X9c9g1wYOft00jWryzO1Yv7N8-2FHtdkmy9lj3HDm0mgwrc7dx-2FAeLCNhnqw-2FZB8PzjCh= c2vwXnzPir7EVkLNkyfI-2F59U9WM0-2Bm0iKjbKos9-2FMnPVn7uEB29AfOys2-2FftYePDtv2= 9KPZlPA0SriBSyK5MaV-2F26Qga2awIugXM6Z9xF9X3E7zbFFhu6OwlzgiT2Wk-2By-2BPWK75X= fkghEiI08M0qs2-2FcsUG3iyEQAvzWV7HksEKxCsGyiwx2uSmu-2FNm9euJQGgt-2F4-3D =C2=A0 This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ= yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1= 8dK5MiuQ-3D-3DFW4V_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS= l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYOft00jWryzO1Yv7N8-= 2FHtdkmy9lj3HDm0mgwrc7dx-2FAeLCNhnqw-2FZB8PzjChc2vwXnzPir7EVkLNkyfI-2F59U9W= M0-2Bm0iKjbKos9-2FMnPVn7uAwjR1AfwENZlcAW0ifmWUtxOvc5f8o82wM5cefMEwM-2Bp-2By= yVe4Uu4iA3xaRs71BlT-2B2ZvHteT1oRES-2FmeKgaMLxK20iEPcMpntmz54euTNmmJGFO0SyfL= -2BcHWtutvxsJbZQPg7OnehiOE0XuTyfnxE-3D . Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, =C2=A0Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0=C2=A0 =C2=A0=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With 7 500 people in approxima= tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i= n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit= ter: @UCB_news Image Chart 1 July 10 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED= -2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek685axVcn3p-2B-2FENjGJA-2Fz29Pz4= -2FWV3rnOZ-2BHzQCdaDbcDQqXea19TaA3DkSpmDh8Q-3DhUxr_xDPID0vOuylFAU8fv4e60wei= 4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekoc= Vj-2F2X9c9g1wYOft00jWryzO1Yv7N8-2FHtdkmy9lj3HDm0mgwrc7dx-2FAeLCNhnqw-2FZB8P= zjChc2vwXnzPir7EVkLNkyfI-2F59U9WM0-2Bm0iKjbKos9-2FMnPVn7uMENfBuWtld7LOgt-2B= hjEf6-2Fodpv4sRLPuOF0nkebboTPDFrs7P3-2BAtQfUUvVeyqCGeODF6ge7SIpa9vUve01Xn-2= Bpkd5KdwTNVzaldCtZDk0tUKGvBlOpe-2FHP39OzScqSrO-2BdmEibIVoH0SzHTfTSGqg-3D Im= age Chart 2 July 10 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED= -2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek685axVcn3p-2B-2FENjGJA-2Fz218NR= D0Rls2dpHe6LmmGzi9fxCaWxrS75j9M13-2BvIvWU-3DPj9C_xDPID0vOuylFAU8fv4e60wei4J= xqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj= -2F2X9c9g1wYOft00jWryzO1Yv7N8-2FHtdkmy9lj3HDm0mgwrc7dx-2FAeLCNhnqw-2FZB8Pzj= Chc2vwXnzPir7EVkLNkyfI-2F59U9WM0-2Bm0iKjbKos9-2FMnPVn7uFeXn92BU95BxI3VN1hsE= 7w1i9EQqhGoY1vTaasaJCAEDGmJsPXKhj4ClXi1II0-2FTLs1B-2BT6E1DMZfsIMMrelDdLscGZ= M1qWgRgTd3cGoULDPCzwgwie3C3J5vzTa0EEpTYf4xbHgxJfPWivSFjdx-2Bs-3D GenericFile 200710 - UCB Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/c= lick?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek685axVcn3p-2B-2= FENjGJA-2Fz2jOM-2F7XOdikfCE9WkMCTLlTd84DsribzSEejtVcXNA-2FY-3D9FJE_xDPID0vO= uylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Z= lf-2FOeoCOG9ekocVj-2F2X9c9g1wYOft00jWryzO1Yv7N8-2FHtdkmy9lj3HDm0mgwrc7dx-2F= AeLCNhnqw-2FZB8PzjChc2vwXnzPir7EVkLNkyfI-2F59U9WM0-2Bm0iKjbKos9-2FMnPVn7uLr= PgAdtAp6yl7WvTwNAWVRhwEzSqdxbV8lACeCR5IW2kbX6TeCkX1tKh-2BnzzI0spSeitN9wE7O-= 2FGFSjEqdA-2FKnsZH5wkhljQ-2BmbW1lQiba2oSszI-2F43oFqV9hK2hf5Sf-2B3Zf7Mc-2BMW= VVePXK-2BLf9dw-3D GenericFile 200710 - Ali=C3=A9nation d actions propres (https://u7061146.ct.sendgrid.ne= t/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek685axVcn3= p-2B-2FENjGJA-2Fz2VwTNGmrtpYQidEVAXL6dt77VlHEBEiujXSPZQ-2F9k0yY-3DRB7v_xDPI= D0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlG= B52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYOft00jWryzO1Yv7N8-2FHtdkmy9lj3HDm0mgwrc7d= x-2FAeLCNhnqw-2FZB8PzjChc2vwXnzPir7EVkLNkyfI-2F59U9WM0-2Bm0iKjbKos9-2FMnPVn= 7uM89i0OJad99dG4JOl5Et4RESvjPr48S1vOYOyw-2FsoabCYnHfOxzUBUl1u0WCcL7uCRaqd7q= NqVf4gSvA58WR4RdpvbVdiFZwgQYdpCC68zX-2BYuGET58QiGCuEE2-2FlNpXfvDaH2HOo-2Bir= 8LGn3haNNo-3D GenericFile 200710 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.net/= ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek685axVcn3p-= 2B-2FENjGJA-2Fz2-2BLhYSaj8mqsFVE9Ys7SE6Hx-2BfeQ8sUuhUHrwbqnbqBA-3DVBJu_xDPI= D0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlG= B52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYOft00jWryzO1Yv7N8-2FHtdkmy9lj3HDm0mgwrc7d= x-2FAeLCNhnqw-2FZB8PzjChc2vwXnzPir7EVkLNkyfI-2F59U9WM0-2Bm0iKjbKos9-2FMnPVn= 7uA4DmToToO3-2B9-2F6-2Bccj3BGAo1Qk9HpFROo-2B08BntH7UljseIf5W-2BKWW68kgx5ehh= uup-2BL2bYglIQXZVPR2QG3uJ1RrIBC14I63Ps2nssewj1wSVtk11XeeZjQapyra2-2F7IoRv3d= 1mp7rgPPjgmsqzCc-3D=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT= UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXViUUjcp3MZ7Qr52o31JRQfV1RNsmOwm= eSnWtugDMd962L4Of2-2BLy8V02EQY-2BtsSbYwgq4GLr8ikj0WNpPiQ2yl64pkHaJH4aSZAAAC= cEHrg-3D-DWN_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvP= s6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYOft00jWryzO1Yv7N8-2FHtdk= my9lj3HDm0mgwrc7dx-2FAeLCNhnqw-2FZB8PzjChc2vwXnzPir7EVkLNkyfI-2F59U9WM0-2Bm= 0iKjbKos9-2FMnPVn7uI-2BuYh-2FC-2FnU1Q53S4UFid718WwiFQattAJZZ7h1yC36SApRaGwe= PmeOJ66ZaUpQy8JE1iZty3PdwGm6XEPLb1-2FNLaZvQZ6sEF0ubEjF7OroQ7RrPXJZIR1M3gcPm= PN-2BLr-2B9n6wTv-2F35zu4VXdYkOjc0-3D=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=

UCB's latest news

22/04/2024 07:01

UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Transparency directive : regulatory news

UCB's latest news

Other stories